Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Moving on After Breast Cancer: support for breast cancer survivors with depression in Pakistan

Official title: Clinical and Cost-effectiveness of an Integrated Psychosocial Care Plan for Comorbid Depression in Breast Cancer Survivors In Pakistan: A Sequential Multiple Assignment Randomised Trial

Run by Pakistan Institute of Living and Learning · NCT07015944 · Data updated 2026-11-12

This trial will test a three-stage adaptive program to see if it helps breast cancer survivors in Pakistan who have major depression feel better and lowers care costs.

More Major Depressive Disorder (MDD) trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment26376 (estimated)
SponsorPakistan Institute of Living and Learning
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Karachi, Sindh)
StatusRecruiting
StartedJune 13, 2025
Main results expectedDecember 30, 2028
Study endsDecember 30, 2028
Registry record updatedMarch 18, 2026
Trial IDNCT07015944 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18 or older who are breast cancer survivors who have completed initial treatment and have a PHQ-9 score of 10 or more with a current Major Depressive Episode confirmed by SCID are ideal candidates.

Probably not a fit

Patients with severe medical or psychiatric conditions preventing participation (including those with advanced symptomatic metastatic disease requiring daily symptom control), those lacking capacity to consent, or those without current depression are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This large SMART (Sequential, Multiple Assignment, Randomised Trial) will enrol about 26,372 women breast cancer survivors aged 18 and older who completed initial cancer treatment and screen positive for depression (PHQ-9 ≥10) with diagnosis confirmed by SCID. Participants will be recruited from primary care units, outpatient and oncology clinics in public hospitals, and charitable organisations across Pakistan and randomised to a stepped, adaptive intervention pathway versus enhanced usual care. The adaptive pathway uses non-specialist delivered low-intensity guided self-help, a tailored 'Moving on After Breast Cancer (ABC) plus' approach, and standardised antidepressant treatment, with progression determined by response at each stage. Outcomes include clinical depression symptoms and cost-effectiveness of the three-stage program.

Why it matters

Potential benefit: If successful, the program could reduce depressive symptoms and improve daily functioning while providing a scalable, affordable care model for breast cancer survivors in Pakistan.

How similar studies have gone: Task-shared, low-intensity psychological interventions and stepped-care models have shown benefit for depression in LMICs and general medical populations, but large-scale SMART trials specifically for breast cancer survivors in LMICs are novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women
* Aged 18 years and above
* Diagnosed with breast cancer (any stage)
* Completed initial treatment (i.e., surgery and/or radiotherapy or chemotherapy) for breast cancer (even if they are currently on hormonal therapy post-initial treatment)
* Total score of 10 or above on the Patient Health Questionnaire (PHQ-9)
* Diagnosis of current Major Depressive Episode (MDE) confirmed using the Structured Clinical Interview for DSM-5 (SCID).

Exclusion Criteria:

* Lacking capacity to provide informed consent, such as those identified by clinicians as having intellectual disabilities, dementia, or severe medical and/or psychiatric illnesses requiring hospitalisation
* Unable to engage in assessments or interventions, including those with stage 4 breast cancer experiencing significant symptoms (e.g., metastatic lesions in the lungs, liver, or bones requiring daily treatment for symptomatic relief, such as the daily use of two or more painkillers), which restrict their capacity to participate
* Currently receiving psychological therapy or taking antidepressant medications (e.g., SSRIs, SNRIs, or other prescribed antidepressants)

Where it's running

  • Pakistan Institute of Living and Learning
    Karachi, Sindh, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.